US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 219 | 46 | 7 | 173 | 239 |
| Receivables | 49 | 20 | 9 | 0 | 2 |
| TOTAL | $269 | $67 | $16 | $176 | $320 |
| Non-Current Assets | |||||
| PPE Net | 8 | 9 | 1 | 1 | 1 |
| Other Non-Current Assets | 10 | 10 | 55 | 55 | 55 |
| TOTAL | $18 | $19 | $55 | $55 | $56 |
| Total Assets | $288 | $86 | $71 | $231 | $376 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 |
| Accounts payable and accrued liabilities | 2,917 | 2,799 | 2,724 | 2,907 | 3,582 |
| Accrued Expenses | 2,368 | 4,480 | 4,531 | 4,411 | 4,821 |
| Other current liabilities | 478 | 882 | 465 | 465 | 465 |
| TOTAL | $11,410 | $13,833 | $13,440 | $13,395 | $13,324 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,051 | N/A | 281 | 648 | 1,069 |
| TOTAL | $1,051 | $N/A | $281 | $648 | $1,069 |
| Total Liabilities | $12,462 | $13,833 | $13,721 | $14,044 | $14,393 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 466 | 421 | 347 | 237 | 201 |
| Common Shares | 631 | 595 | 669 | 598 | 591 |
| Retained earnings | -117,504 | -118,181 | -117,454 | -116,307 | -115,557 |
| TOTAL | $-12,174 | $-13,747 | $-13,651 | $-13,812 | $-14,017 |
| Total Liabilities And Equity | $288 | $86 | $70 | $231 | $376 |